News
STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
More in Health
- Congress allocated $1.3 billion that the trump administration hasn't spent NPR — Health
- Risk from toxic metals can persist months after wildfires, Maui study finds STAT
- High screen usage in children linked to poorer outcomes, major study suggests The Guardian — Society
- Ten NHS staff removed over Noah Woods data breach BBC News — Health
- Pennsylvania Measles Outbreak Grows to Nearly 900 Cases The New York Times — Health